Very rapidly, the answer is yes, and we've started.
I'm proud to report that when I was president of the Fonds de recherche en santé du Québec, before holding this current job, I called upon CIHR when there was the scare of C. difficile in Quebec—as you know, a few years back—to work with CIHR to develop a major program of research on ways to diagnose early and find new ways of treating C. difficile. The probiotics studies that you referred to was some of the work that we funded at the time. It is part of our priority research in what we call emerging threats.